• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES EDWARDS SAPIEN 3 TRANSCATHETER; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES EDWARDS SAPIEN 3 TRANSCATHETER; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED Back to Search Results
Model Number 9600TFX29A
Device Problems Perivalvular Leak (1457); Incomplete Coaptation (2507); Failure to Align (2522); Malposition of Device (2616); Activation, Positioning or Separation Problem (2906)
Patient Problems Failure of Implant (1924); Tricuspid Regurgitation (2112); No Code Available (3191)
Event Date 06/05/2020
Event Type  Injury  
Event Description
As reported, during a tf thv valve within a tricuspid ring case, three 29mm sapien 3 valves were used.The first valve (sn (b)(4)), implanted with an additional 5cc, was deployed with an "imperfect position".The valve was not seated properly into the surgical ring, and appeared to be canted.A second valve (sn (b)(4)) was implanted within the first with an additional 10cc, but lacked proper leaflet coaptation and exhibited central ai.One of the valve leaflets was noticeably ¿frozen¿ or not moving efficiently.A third valve (sn (b)(4)) was implanted with an additional 6cc, which rectified the leaflet coaptation issue but a plug was still needed for pvl around the first thv and surgical ring.Per the records received, the annuloplasty ring was not well aligned within the native tricuspid valve and the fist valve was therefore implanted more atrial than ideal.The decision was made to flare the ventricular side of the first valve by post-dilating it with +8cc before implanting the second valve more ventricular.After the second valve was placed, one of the leaflets of this new valve appeared to be "malfunctioning and not moving", resulting in moderate to severe transvalvular tricuspid regurgitation.The third valve was placed slightly more ventricular than the second valve with +10cc.There was evidence of paravalvular leak around the transcatheter valves, lateral to it, and the ring.The decision was made to fix the pvl, which was plugged.
 
Manufacturer Narrative
Please reference related manufacturer report no: 2015691-2020-12294.
 
Manufacturer Narrative
Corrected data: f10, h6.Reference capa-20-00141.
 
Manufacturer Narrative
Corrected data: f10, h6.Reference capa-20-00141.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EDWARDS SAPIEN 3 TRANSCATHETER
Type of Device
AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED
Manufacturer (Section D)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
MDR Report Key10201010
MDR Text Key199096041
Report Number2015691-2020-12293
Device Sequence Number1
Product Code NPT
Combination Product (y/n)N
PMA/PMN Number
P140031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Remedial Action Other
Type of Report Initial,Followup,Followup,Followup
Report Date 06/05/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/26/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date10/22/2021
Device Model Number9600TFX29A
Device Lot Number7121491
Was Device Available for Evaluation? No
Date Manufacturer Received07/23/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age75 YR
-
-